BridgeBio Oncology Therapeutics, Inc. (BBOT) Misses Q2 EPS by 70468c
Tweet
Share
E-mailGet Alerts BBOT Hot Sheet
Join SI Premium – FREE
BridgeBio Oncology Therapeutics, Inc. (NASDAQ: BBOT) reported Q2 EPS of ($705.20), $704.68 worse than the analyst estimate of ($0.52).
For earnings history and earnings-related data on BridgeBio Oncology Therapeutics, Inc. (BBOT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Corning (GLW) files for up to $2B offering of common shares
- JPMorgan cut off lending activity for Situational Awareness - FT
- Northrop Grumman wins two U.S. defense contracts worth $38.7m
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
